No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemiae typo cellulari non specificato
Similar endpoints
↥List of similar endpoints to
Leukaemia of unspecified cell type
based on the number of shared cases.
Similar with more cases:
- Leukaemia of unspecified cell type
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 303 | 132 | 171 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.08 |
| Median age at first event (years) | 62.58 | 56.99 | 66.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 298
- Matched controls
- 2978
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
360.4
212.3
193
15
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
211.5
177
*
XW000
NOMESCO Finland
Bone marrow biopsy
122.0
150.6
155
26
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
133.7
118
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
93.8
85
*
WW500
NOMESCO Finland
Blood transfusion
57.7
84.0
98
25
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
69.9
79.0
89
18
L03AA02
ATC
filgrastim; parenteral
+∞
68.4
63
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
65.0
60
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
59.4
55
*
A04AA01
ATC
ondansetron; systemic, rectal
40.5
59.1
74
24
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
565.5
49.9
48
*
A05AA02
ATC
ursodeoxycholic acid; oral
107.0
49.7
53
6
H02AB02
ATC
dexamethasone; systemic
67.0
48.5
55
10
127
Kela drug reimbursment
Transplant complication
72.8
48.2
54
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.1
47.9
114
189
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
15.0
45.4
79
70
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.9
42
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.6
43.5
72
56
J05AB11
ATC
valaciclovir; oral
8.5
41.2
100
166
ZX120
NOMESCO Finland
Intravenous
11.0
39.8
81
98
L01BB02
ATC
mercaptopurine; oral
83.2
39.1
43
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
67.5
36.2
41
7
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
35.1
33
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
35.1
33
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
35.1
33
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
377.8
34.7
34
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
33.9
62
59
M04AA01
ATC
allopurinol; systemic
6.6
32.8
96
201
R50.9
ICD-10 Finland
Fever, unspecified
6.7
32.6
93
188
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
30.0
179
786
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
29.7
28
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.5
29.4
101
254
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
28.6
27
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
28.6
27
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.9
27.6
75
139
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
27.5
26
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
12.5
26.2
48
45
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.5
25.8
44
35
L04AD01
ATC
ciclosporin; systemic
22.4
23.6
34
17
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.5
23.1
46
51
ZX090
NOMESCO Finland
Other technic of radiotherapy
129.9
22.9
24
*
WW200
NOMESCO Finland
Immunization
14.9
22.1
37
28
J01MA12
ATC
levofloxacin; systemic
4.4
21.5
90
267
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
23.7
21.3
30
14
L03AA13
ATC
pegfilgrastim; parenteral
+∞
21.1
20
*
L01XX05
ATC
hydroxycarbamide; oral
25.6
20.4
28
12
189
Kela drug reimbursment
Imatinib
+∞
20.0
19
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
21.2
19.9
29
15
J02AC03
ATC
voriconazole; systemic
213.5
19.8
20
*
TAB00
NOMESCO Finland
Lumbar puncture
9.2
19.8
42
52
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
19.7
63
140
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
18.9
18
*
L01XE01
ATC
[U] imatinib; oral
+∞
18.9
18
*
Z51.5
ICD-10 Finland
Palliative care
16.5
18.9
30
20
A41.9
ICD-10 Finland
Sepsis, unspecified
10.9
18.2
35
36
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.8
18.1
24
9
N02AA05
ATC
oxycodone; systemic
5.2
18.1
60
138
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
17.8
68
182
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
53.3
17.2
20
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
16.4
17.0
27
18
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.9
16.8
36
45
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
B73
ICPC
Leukaemia
+∞
16.8
16
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
50.5
16.2
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
15.9
111
482
H02AB09
ATC
hydrocortisone; systemic
11.0
15.8
30
30
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.8
15
*
ZX121
NOMESCO Finland
Central venous catheter
+∞
15.8
15
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
15.8
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
168.4
15.6
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.7
14
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
14.7
14
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
14.7
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
157.3
14.6
15
*
ZX112
NOMESCO Finland
Subcutaneous
35.9
13.6
17
5
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
13.6
13
*
J02AC04
ATC
posaconazole; systemic
+∞
13.6
13
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
13.6
13
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
13.6
13
*
TPH00
NOMESCO Finland
Phlebotomy
146.3
13.6
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
12.6
12
*
2AX04
NOMESCO Finland
NA
+∞
12.6
12
*
J05AB01
ATC
aciclovir; systemic
3.1
12.5
80
319
L04AA06
ATC
mycophenolic acid; systemic
14.2
12.1
20
15
J01MA14
ATC
moxifloxacin; systemic
4.4
11.9
44
112
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
67.6
11.7
13
*
JN4AD
NOMESCO Finland
Body CT examination
7.5
11.6
27
39
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
11.5
11
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
11.5
11
*
130
Kela drug reimbursment
Malignant tumour
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
11.5
11
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
11.5
11
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
124.5
11.5
12
*
ZX131
NOMESCO Finland
Intrathecal
124.5
11.5
12
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
36.6
11.4
14
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
17.9
11.3
17
10
D70.82
ICD-10 Finland
Drug-induced neutropenia
26.2
11.2
15
6
ZX108
NOMESCO Finland
Inhalation
45.1
11.0
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
45.1
11.0
13
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
10.8
93
440
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
10.8
36
83
5BA08
NOMESCO Finland
NA
62.2
10.7
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
113.8
10.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
113.8
10.5
11
*
2089X
ICD-9 Finland
Leukaemia of unspecified cell type, Unspecified leukaemia
+∞
10.5
10
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
10.5
10
*
1DB06
NOMESCO Finland
NA
+∞
10.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
152
Kela drug reimbursment
Nilotinib
+∞
10.5
10
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
24.4
10.3
14
6
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.4
10.3
22
28
A07AA02
ATC
nystatin; oral
5.3
10.2
31
64
L02BA01
ATC
tamoxifen; oral
41.5
10.0
12
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
9.4
9
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
ZX114
NOMESCO Finland
Intramuscular
14.3
9.3
15
11
212
Kela drug reimbursment
Gout
10.5
9.1
17
17
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
9.1
82
393
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.5
9.1
23
38
H02AB04
ATC
methylprednisolone; systemic
3.0
9.1
56
215
N05BA06
ATC
lorazepam; systemic, sublingual
5.0
8.9
28
61
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
51.5
8.7
10
*
L02BG04
ATC
letrozole; oral
20.7
8.5
12
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
8.5
129
789
1XC02
NOMESCO Finland
NA
92.5
8.5
9
*
TPX15
NOMESCO Finland
Removal of vascular injection port
92.5
8.5
9
*
J02AC01
ATC
fluconazole; systemic
2.2
8.4
110
628
A41.8
ICD-10 Finland
Other specified sepsis
11.2
8.4
15
14
2AA01
NOMESCO Finland
NA
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
8.4
8
*
316
Kela drug reimbursment
Imatinib
+∞
8.4
8
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
8.4
8
*
150
Kela drug reimbursment
Dasatinib
+∞
8.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.2
8.2
19
28
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.6
8.2
23
44
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.4
8.2
40
131
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
8.2
35
103
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
34.3
8.1
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.0
8.0
21
37
R4110
NOMESCO Finland
Physiotherapy
2.4
8.0
79
394
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
13.5
7.9
13
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
7.7
89
478
B01AB05
ATC
enoxaparin; parenteral
2.2
7.6
85
450
L04AA01
ATC
[U] ciclosporin; systemic
10.4
7.6
14
14
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
82.0
7.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
82.0
7.4
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
7.4
30
84
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
7.3
7
*
L01XE08
ATC
[U] nilotinib; oral
+∞
7.3
7
*
1XX02
NOMESCO Finland
NA
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.7
7.3
31
91
ZZR00
NOMESCO Finland
Flap of skin
30.8
7.2
9
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.6
7.0
31
94
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.8
113
702
6BA02
NOMESCO Finland
NA
41.0
6.8
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.7
40
151
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
6.7
29
87
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
71.3
6.4
7
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
71.3
6.4
7
*
B02.9
ICD-10 Finland
Zoster without complication
3.9
6.4
25
69
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.4
6.3
11
10
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
6.3
6
*
L01EA03
ATC
nilotinib; oral
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
5AD01
NOMESCO Finland
NA
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
6.3
6
*
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
1CX01
NOMESCO Finland
NA
+∞
6.3
6
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
27.3
6.3
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.6
6.2
27
81
HA1AA
NOMESCO Finland
X-ray mammography
6.3
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042111) Morphology [Interpretation] in Bone marrow Narrative
86
26
45.79
139.21
5.8
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
165
209
16.14
136.26
17.5
2.8
u/l
397.4
236.8
2.35
160
196
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
71
11
83.99
132.06
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
71
12
76.97
130.15
2.6
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
74
16
60.87
129.50
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
82
43
25.77
108.87
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
77
35
29.15
108.21
1.4
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
87
67
17.81
95.44
1.3
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
75
43
22.85
95.30
1.3
1.1
u/ml
247.8
183.3
1.00
48
18
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
63
33
23.84
82.87
4.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
60
30
24.69
80.40
1.2
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
33
22.89
79.02
3.6
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
50
17.57
77.56
1.7
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
48
14
40.55
77.05
1.8
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
135
263
8.45
73.83
9.7
2.5
%
1.6
1.7
0.07
126
238
(3017181) Myelocytes/100 leukocytes in Blood
98
132
10.50
73.34
9.7
3.9
%
1.2
0.8
0.93
57
27
(3023520) Reticulocytes [#/volume] in Blood
113
190
8.89
70.19
8.0
2.4
e9/l
59.9
66.9
0.91
90
158
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
22
26.38
68.19
4.1
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
41
11
42.95
67.03
1.7
1.5
mg/l
3.1
2.8
0.18
35
11
(3012095) Magnesium [Moles/volume] in Serum or Plasma
132
287
7.38
63.91
13.2
3.1
mmol/l
0.8
0.8
2.08
125
266
(3021879) Hepatitis B virus core Ab [Presence] in Serum
83
111
9.92
61.83
1.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
41
15
31.45
61.15
8.7
4.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
84
118
9.47
60.06
9.0
4.1
%
0.7
0.3
1.59
35
18
(3016650) Hepatitis A virus Ab [Presence] in Serum
50
33
17.95
58.45
1.2
1.1
—
—
—
0
0
(44806118)
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
(44790049)
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
(44790047)
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
(44790048)
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
82
125
8.62
54.47
10.1
4.0
%
1.0
0.1
0.70
55
23
(3017143) Hepatitis C virus Ab [Presence] in Serum
105
219
6.81
51.87
1.6
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
119
288
6.16
50.12
16.8
5.0
mmol/l
1.1
1.1
0.35
114
261
(3025159) Blasts/100 leukocytes in Blood
76
123
7.91
47.54
9.3
4.0
%
8.7
0.0
1.85
41
21
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
32
12
29.70
47.03
4.6
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
110
270
5.83
45.10
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
18
20.45
41.86
2.1
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
61
89
8.33
41.52
1.7
1.8
g/l
1.7
1.4
0.84
45
79
(3011412) CD3 cells [#/volume] in Blood
31
15
22.91
41.35
6.5
2.0
e9/l
1.2
1.1
—
18
10
(3020630) Protein [Mass/volume] in Serum or Plasma
79
162
6.24
38.86
3.7
1.7
g/l
63.7
67.1
2.82
74
140
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
29
14
22.80
38.65
2.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
28
14
21.93
36.74
1.8
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
32
22
16.14
36.18
4.6
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
175
731
4.30
35.01
26.8
5.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
110
330
4.66
34.42
4.0
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
146
543
4.26
34.20
14.9
3.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
13
21.78
34.05
5.0
2.1
%
10.1
10.8
—
12
8
(3026493) Urate [Moles/volume] in Serum or Plasma
147
556
4.19
33.50
10.6
2.3
umol/l
307.0
5580.0
2.07
142
490
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
16
18.43
32.77
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
27
16
18.43
32.77
5.0
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
29
12.65
32.34
1.5
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
65
132
6.00
31.95
3.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
110
349
4.38
31.67
1.6
1.9
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
29
0
+∞
30.75
1.0
0.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
37
42
9.90
30.45
7.8
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
14
18.53
29.26
5.8
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
14
18.53
29.26
5.8
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
14
18.53
29.26
5.8
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
15
17.29
28.29
1.6
2.5
%
34.4
52.1
—
7
7
(4035726)
40
56
8.08
27.83
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
11
20.44
26.79
4.5
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
81
234
4.36
25.91
2.6
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
193
995
3.59
25.67
27.1
5.0
%
0.6
0.7
1.11
188
917
(3019069) Monocytes/100 leukocytes in Blood
197
1031
3.60
25.53
28.7
5.3
%
9.7
8.7
1.28
191
953
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
233
4.31
25.26
2.7
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
53
7.81
25.19
7.9
1.3
e6/l
6.3
625.1
0.97
27
43
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
53
7.81
25.19
7.9
1.2
e6/l
1.5
3.5
1.35
26
42
(3006504) Eosinophils/100 leukocytes in Blood
195
1024
3.54
24.92
27.5
5.0
%
2.2
3.0
7.46
190
942
(3002030) Lymphocytes/100 leukocytes in Blood
198
1055
3.53
24.60
27.9
5.0
%
30.2
28.8
0.69
192
971
(40758292) HTLV I+II Ab panel - Serum
23
0
+∞
24.29
1.4
0.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
23
0
+∞
24.29
1.1
0.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
20
12
17.77
23.93
1.3
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
212
1213
3.49
22.74
46.5
6.1
e9/l
3.2
4.3
1.83
200
1048
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
24
22
11.76
22.72
1.5
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
198
1094
3.34
22.38
24.3
4.9
e9/l
0.7
0.6
0.20
186
934
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
18
13.10
22.31
1.4
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
16
14.03
22.18
1.0
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
198
1099
3.31
22.10
24.4
4.9
e9/l
0.0
0.0
5.77
185
939
(3044640) Blood type and Crossmatch panel - Blood
135
602
3.24
21.95
12.2
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
199
1124
3.24
21.24
24.8
4.9
e9/l
2.1
1.9
0.19
188
977
(3013115) Eosinophils [#/volume] in Blood
200
1139
3.22
20.92
28.3
5.2
e9/l
0.1
0.2
6.50
186
993
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
20
11.78
20.89
1.5
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
167
866
3.07
20.50
16.9
3.7
g/l
33.5
35.8
5.68
162
802
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
14
14.41
20.40
1.5
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
14
14.41
20.40
1.5
2.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
24
26
9.94
20.24
10.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
21
19
11.80
19.98
6.6
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
53
135
4.55
19.64
2.6
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
132
612
3.05
19.61
13.0
2.9
ph
7.4
7.4
0.49
24
89
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
22
10.70
19.60
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
457
3.16
19.26
6.7
1.7
mg/l
3.7
1.1
1.52
96
350
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
169
907
2.95
19.08
15.0
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
108
454
3.14
18.95
11.1
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
104
429
3.17
18.84
14.0
4.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
57
6.37
18.80
2.6
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
177
981
2.93
18.70
20.9
5.6
mmol/l
1.2
1.2
1.30
168
880
(3048879) Bone marrow aspiration report
22
5
47.27
18.50
5.6
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
186
1072
2.90
18.03
23.8
6.0
mmol/l
1.2
1.2
0.89
161
930
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
60
6.05
17.85
2.3
3.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
5
44.97
17.52
6.7
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
16
0
+∞
16.82
19.4
0.0
umol/l
0.5
—
—
16
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
10
14.63
15.14
2.2
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
19
6
33.63
14.99
6.4
1.5
e9/l
0.2
0.2
—
19
6
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
14
0
+∞
14.70
10.2
0.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
35
6.37
12.30
2.6
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
68
275
2.90
12.23
2.3
2.5
%
31.2
24.1
1.28
59
238
(40758558) Short blood count panel - Blood
103
514
2.52
12.22
36.9
4.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
6
28.02
12.17
7.6
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
6
28.02
12.17
7.6
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
6
28.02
12.17
7.6
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
65
263
2.87
11.64
1.8
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
82
4.25
11.61
6.7
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
143
842
2.32
11.57
13.3
9.1
inr
1.3
1.3
0.00
40
216
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
121
3.66
11.55
2.9
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
24
7.44
11.54
4.7
1.5
pg
35.4
34.0
0.65
17
24
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.53
14.0
0.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
74
4.39
11.43
3.0
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
93
457
2.49
11.28
2.1
1.3
g/l
1.8
2.6
5.54
81
246
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
16
9.13
11.20
1.1
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
9
18.68
10.84
7.8
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
9
18.68
10.84
7.8
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
9
18.68
10.84
7.8
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
9
18.68
10.84
7.7
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
152
939
2.24
10.73
4.6
2.7
ug/l
535.3
121.0
6.84
143
858
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
24
52
4.93
10.67
5.0
1.3
—
1.2
—
0
5
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
117
650
2.30
10.67
5.1
2.2
u/l
52.2
57.1
0.98
112
596
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
105
559
2.34
10.56
1.9
2.2
mg/l
3.2
2.9
0.67
91
466
(3003694) ABO and Rh group [Type] in Blood
103
545
2.35
10.49
2.3
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
34
5.90
10.36
5.8
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
73
4.12
9.92
2.4
1.1
g/l
9.8
10.7
0.19
23
58
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
27
69
4.20
9.82
2.4
1.1
g/l
2.0
0.3
0.43
22
58
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
79
3.95
9.69
2.3
1.2
g/l
3.5
3.2
0.94
23
57
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
41
5.15
9.45
1.2
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
9
0
+∞
9.42
4.4
0.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
81
3.85
9.36
2.3
1.2
g/l
3.5
4.0
1.25
23
56
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
81
3.85
9.36
2.3
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
81
3.85
9.36
2.3
1.2
g/l
7.4
7.7
0.40
23
58
(3015377) Calcium [Moles/volume] in Serum or Plasma
116
671
2.18
9.35
5.7
2.0
mmol/l
2.3
2.4
4.16
109
544
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
17
7.95
9.34
6.5
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
17
7.95
9.34
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
7
19.32
9.01
1.9
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
5
24.89
8.98
3.7
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
5
24.89
8.98
3.7
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
18
7.50
8.91
6.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
18
7.50
8.91
6.5
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
18
7.50
8.91
6.5
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
18
7.50
8.91
6.5
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
18
7.50
8.91
6.5
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
9
13.82
7.44
1.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
143
956
1.94
7.32
36.3
7.3
e9/l
0.0
0.0
0.56
124
758
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
7
0
+∞
7.32
5.7
0.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
7
0
+∞
7.32
1.9
0.0
%
13.7
—
—
7
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
7
0
+∞
7.32
4.0
0.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
35
4.77
7.01
9.3
2.7
%
47.6
57.6
1.07
16
35
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
31
5.04
7.01
1.1
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
60
297
2.27
6.86
2.0
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
9
12.62
6.63
1.7
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
35
141
2.68
6.21
6.7
4.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
118
775
1.86
6.11
5.7
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
189
1435
1.84
6.08
5.5
4.4
e6/l
26.0
5329.4
—
5
25
(3000093) Morphology [Interpretation] in Blood Narrative
13
28
4.81
5.79
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
5
16.37
5.44
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
34
4.27
5.42
2.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
51
260
2.16
5.38
3.8
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
178
2.37
5.34
1.3
1.8
—
—
—
0
0
(3019225) pH of Specimen
42
200
2.28
5.22
12.6
3.4
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
104
2.75
5.22
3.9
1.5
ug/l
3.7
5.5
0.24
22
81
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
40
3.89
5.15
5.8
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
99
646
1.79
5.07
2.4
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
9
10.26
5.06
1.0
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
45
224
2.18
5.03
11.3
8.2
%
94.7
94.9
0.08
40
215
(3019309) Folate [Moles/volume] in Red Blood Cells
73
436
1.89
4.95
1.9
1.7
nmol/l
1203.6
1147.7
0.20
64
331
(3000850) Epithelial cells [#/volume] in Urine
74
444
1.88
4.95
3.9
2.3
e6/l
4.2
5.3
0.70
69
377
(3003396) Base excess in Arterial blood by calculation
48
248
2.11
4.89
10.8
7.9
mmol/l
1.6
1.4
0.10
34
186
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
62
3.20
4.88
33.1
5.8
mg/l
1.2
1.5
1.48
19
56
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
24
4.72
4.82
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
24
4.72
4.82
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
7
11.69
4.81
3.6
1.1
%
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
33
4.07
4.76
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
53
3.34
4.69
2.4
1.8
u/l
9.4
6.4
0.50
11
47
(3026782) Osmolality of Urine
71
429
1.86
4.62
3.9
2.5
mosm/kgh2o
574.2
567.5
0.09
66
345
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
5
14.28
4.59
1.4
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
5
14.28
4.59
1.4
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
8
10.23
4.54
1.5
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
8
10.23
4.54
1.1
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
9
12
7.69
4.38
1.2
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
7
6
11.90
4.29
1.6
1.2
mg/l
87.6
55.3
—
7
6
(3017732) Neutrophils [#/volume] in Blood
33
155
2.27
4.24
3.5
2.6
e9/l
3.4
3.8
0.29
28
116
(3026008) Bacteria identified in Urine by Culture
95
643
1.70
4.16
4.6
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
96
653
1.69
4.12
5.4
3.0
e6/l
41.4
159.9
0.61
82
499
(3012544) pH of Venous blood
45
242
2.01
4.11
21.4
3.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
124
2.39
4.11
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
105
2.51
4.10
1.6
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
7
10.20
4.03
14.6
1.4
u/l
245.6
220.1
—
7
7
(3019060) Gas panel - Arterial blood
32
152
2.24
4.01
10.5
7.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
48
3.24
3.98
1.1
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
86
576
1.69
3.88
5.5
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
37
190
2.08
3.83
15.4
6.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
8
8.92
3.79
1.4
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
5
12.20
3.78
1.7
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
5
12.20
3.78
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
12
6.81
3.69
2.5
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
56
2.96
3.69
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
56
2.96
3.69
1.4
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
43
237
1.95
3.67
22.3
3.7
mmol/l
2.0
2.0
0.04
34
176
(3018095) Leukocytes [#/volume] in Urine
106
760
1.61
3.63
6.0
3.6
e6/l
15.5
132.0
2.43
85
531
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
44
247
1.91
3.56
10.0
7.9
kpa
4.9
5.1
0.99
39
236
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
6
10.17
3.51
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
6
10.17
3.51
1.2
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
98
700
1.59
3.37
3.5
3.2
ng/l
1161.3
1394.1
0.35
86
583
(3030467) Casts [#/volume] in Urine by Automated count
86
598
1.61
3.30
5.6
2.9
e6/l
0.2
0.4
1.24
71
439
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
7
8.71
3.27
1.2
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
43
247
1.86
3.25
10.2
7.9
kpa
10.7
11.6
0.70
38
236
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
124
945
1.53
3.17
2.0
2.0
pmol/l
87.9
95.7
1.26
84
481
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
5
10.14
2.99
1.2
2.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
13
5.48
2.88
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
31
3.30
2.80
1.0
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
44
269
1.74
2.72
1.2
1.3
titre
330.0
529.2
—
8
65
(3042631) Mycobacterium sp identified in Specimen
8
19
4.29
2.69
1.0
3.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
178
1.89
2.68
3.5
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
114
879
1.48
2.65
3.9
3.8
ng/l
58.0
40.9
0.27
88
607
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
11
5.54
2.55
1.7
1.1
—
—
—
0
0
(4027681)
7
16
4.45
2.49
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
16
4.45
2.49
3.7
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
67
468
1.55
2.47
1.5
1.8
pmol/l
396.7
413.1
0.20
59
391
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
200
2242
0.68
2.47
4.9
4.9
mmol/l
2.7
2.7
0.30
189
2051
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
12
5.08
2.41
2.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
12
5.08
2.41
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
190
1633
1.44
2.40
5.5
4.0
mm/h
18.9
11.3
5.43
182
1492
(3015736) pH of Urine
108
839
1.45
2.37
3.1
3.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
59
2.44
2.33
8.4
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
157
1.86
2.31
6.1
1.8
ml/min/173m2
66.8
62.7
0.19
17
59
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
23
3.54
2.28
1.1
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
18
3.95
2.26
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
9
5.63
2.22
2.6
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
37
2.76
2.12
4.3
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
510
1.48
2.11
3.5
3.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
110
1.98
2.11
18.0
11.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.06
2.08
1.8
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
32
2.87
2.01
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
196
2178
0.72
1.99
4.5
4.4
mmol/l
1.3
1.4
4.48
183
1994
(3002256) Pathology report gross observation
26
150
1.80
1.98
1.8
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
189
1.71
1.97
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
238
2556
0.68
1.95
71.8
17.4
e12/l
3.9
4.5
26.01
233
2466
(3051651) Icteric interference index of Serum or Plasma
5
11
4.60
1.95
13.4
2.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
80
2.06
1.83
1.5
1.6
—
132.0
—
0
5
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
12
4.22
1.83
2.0
1.2
u/l
188.2
316.9
—
5
12
(3035637) Corticotropin [Mass/volume] in Plasma
6
18
3.38
1.75
1.2
2.0
—
—
—
0
0
(3020891) Body temperature
17
89
1.96
1.73
8.2
4.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
175
1530
1.34
1.73
6.1
4.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
13
3.89
1.72
1.6
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
42
2.43
1.69
1.0
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
6
19
3.20
1.67
1.7
1.2
e6/l
1949.3
2633.0
—
6
13
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
7
26
2.73
1.59
1.0
1.2
pmol/l
212.9
254.1
—
7
20
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
20
3.04
1.59
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
62
468
1.41
1.55
5.4
3.8
ng/l
71.8
265.0
1.79
54
377
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
44
2.32
1.55
1.1
1.3
—
—
—
0
0
(4306422)
7
28
2.53
1.46
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
66
2.01
1.45
1.5
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
16
3.16
1.44
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
200
2178
0.76
1.44
6.0
4.5
mmol/l
6.0
6.0
0.03
187
1963
(4268621)
6
23
2.64
1.37
2.5
2.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
5
17
2.97
1.36
1.8
1.2
e6/l
136960.0
22161.4
—
5
9
(3051611) Lipemic interference index of Serum or Plasma
5
17
2.97
1.36
13.6
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
125
1071
1.28
1.32
3.4
3.6
estimate
0.0
0.0
0.00
18
176
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
203
2196
0.77
1.30
5.1
4.4
mmol/l
4.4
4.6
1.62
193
2019
(3048689) Calprotectin [Mass/mass] in Stool
38
271
1.46
1.30
2.4
2.2
ug/g
125.4
121.2
0.03
33
209
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
190
2071
0.78
1.28
4.8
4.4
mu/l
2.1
2.5
0.28
179
1873
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
17
101
1.72
1.22
10.7
7.8
mmol/l
23.2
24.7
0.94
12
90
(4146454)
5
19
2.66
1.22
2.8
3.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
(4062490)
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
126
1092
1.26
1.19
3.5
3.6
estimate
0.0
0.0
0.00
18
171
(40761511) CBC panel - Blood by Automated count
225
2393
0.77
1.18
35.0
11.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
20
2.52
1.15
1.8
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
40
2.03
1.13
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
1.0
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
59
726
0.77
1.04
2.9
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
22
2.29
1.04
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
123
1078
1.24
1.02
4.7
4.9
estimate
0.0
0.0
0.00
18
170
(4010399)
9
160
0.55
1.01
1.2
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
29
0.00
0.98
0.0
1.1
—
3.5
—
0
8
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
349
1.34
0.98
5.6
2.9
e6/l
1.7
2.0
0.13
27
190
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
30
0.00
0.98
0.0
1.0
—
1.3
—
0
15
(3029937) Albumin [Presence] in Urine by Test strip
69
570
1.27
0.95
3.6
3.8
estimate
0.0
0.0
0.00
19
167
(3022217) INR in Platelet poor plasma by Coagulation assay
41
315
1.35
0.95
22.6
24.6
inr
1.4
1.3
—
7
41
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
195
2089
0.81
0.94
5.0
5.9
mmol/mol
39.4
40.2
0.57
183
1930
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
29
2.09
0.90
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
43
1.88
0.88
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
30
2.02
0.87
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
57
1.78
0.84
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
4.5
—
0
14
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.0
—
0.6
—
0
10
(3015235) Bicarbonate [Moles/volume] in Capillary blood
10
59
1.72
0.76
3.2
2.2
mmol/l
24.2
24.4
—
10
49
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
95
837
1.20
0.72
3.2
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
52
621
0.80
0.72
3.6
3.6
%
23.1
23.9
0.13
24
274
(21494755) Public health laboratory ask at order entry panel
14
204
0.67
0.71
1.2
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
27
1.87
0.68
2.6
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
236
0.70
0.68
1.5
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
164
1522
1.17
0.66
5.7
3.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
29
1.74
0.64
1.2
1.3
pmol/l
67.4
56.3
—
5
29
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
49
1.65
0.62
1.6
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
273
1.28
0.61
1.6
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
8
55
1.47
0.56
1.3
1.5
nmol/l
0.9
0.7
—
8
46
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
233
2414
0.85
0.54
37.5
8.2
u/l
30.4
26.1
2.38
227
2298
(3022621) pH of Urine by Test strip
11
158
0.68
0.54
3.1
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
518
0.82
0.54
1.2
1.4
u/ml
4.9
1.6
—
10
127
(3009542) Hematocrit [Volume Fraction] of Blood
200
2095
0.87
0.54
51.1
13.4
%
35.4
40.2
11.14
137
1521
(3012516) Albumin [Mass/volume] in Urine
58
665
0.84
0.54
2.9
3.1
mg/l
1683.6
247.9
0.66
44
433
(3020682) Albumin/Creatinine [Ratio] in Urine
62
703
0.85
0.50
3.4
3.9
mg/mmol
11.7
8.2
0.36
42
452
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
226
1.26
0.50
1.4
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
438
0.82
0.48
2.6
2.5
ug/l
0.6
0.8
0.84
26
274
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
46
1.53
0.48
1.0
1.2
—
1.1
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
274
1.23
0.47
10.7
7.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
48
1.47
0.47
69.6
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
34
284
1.22
0.46
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
77
1.44
0.46
1.4
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
174
0.74
0.44
1.6
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
10
140
0.70
0.44
1.2
1.2
iu/ml
81.0
104.4
—
5
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
128
0.69
0.44
1.8
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
78
1.43
0.43
1.4
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
185
1.26
0.43
7.6
2.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
379
0.83
0.43
1.3
1.3
iu/ml
12.7
34.2
—
9
118
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
32
1.57
0.42
1.4
3.4
—
—
—
0
0
(3013512) EKG study
69
620
1.15
0.42
5.2
3.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
11
79
1.41
0.41
1.9
3.0
g/l
0.4
0.2
—
5
27
(42529406) Shigella sp [Presence] in Stool by Culture
11
79
1.41
0.41
1.4
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
133
1412
0.90
0.40
3.9
3.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
36
1.40
0.38
2.8
1.3
—
—
—
0
0
(3000492) Spirometry study
23
189
1.23
0.37
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
367
1.17
0.37
5.8
2.7
e6/l
0.6
1.0
0.91
25
208
(3021901) Oxygen saturation in Capillary blood
6
41
1.47
0.36
2.3
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
203
2099
0.90
0.35
5.4
4.0
mmol/l
1.5
1.3
3.58
192
1912
(40768443) Skin Pathology biopsy report
11
82
1.35
0.34
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
234
2278
1.12
0.33
53.6
12.0
mg/l
26.8
23.3
0.71
222
1718
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
54
1.30
0.30
1.0
1.3
—
2.7
—
0
10
(40761536) Microorganisms panel - Urine sediment
19
157
1.22
0.30
4.1
3.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.2
—
9.6
—
0
12
(3030981) Hyaline casts [#/volume] in Urine by Automated count
14
112
1.26
0.29
2.4
2.9
e6/l
0.2
0.2
0.19
14
107
(36660697) Celiac disease serology panel - Serum
17
204
0.82
0.28
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
67
1.20
0.26
1.3
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
96
1.26
0.25
2.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
84
0.71
0.24
1.7
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
11
0.00
0.21
0.0
1.0
—
6.7
—
0
11
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
104
0.76
0.21
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
150
1452
1.07
0.19
5.0
2.9
u/l
79.2
45.3
2.14
140
1341
(3009508) Creatinine [Moles/volume] in Urine
69
730
0.93
0.18
2.6
3.0
mmol/l
6.5
7.6
1.19
62
616
(3049717) Cytology report of Urine Cyto stain
6
76
0.79
0.16
1.7
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
78
0.76
0.15
1.0
1.2
—
1.4
—
0
7
(3028300) Cannabinoids [Presence] in Urine
7
86
0.81
0.15
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
86
0.81
0.15
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
87
0.80
0.14
1.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
201
2046
0.95
0.14
33.5
10.8
ml/min/173m2
81.7
79.9
0.40
169
1625
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
141
1.14
0.14
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
113
1.16
0.13
45.0
2.5
%
1.4
1.2
0.54
13
113
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
239
0.91
0.11
1.6
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
115
0.87
0.11
2.4
3.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
46
1.09
0.09
1.6
1.7
g/l
137.6
129.9
—
5
31
(3000475) Leukocytes [#/volume] in Synovial fluid
5
46
1.09
0.09
2.2
1.3
e6/l
4712.8
24664.6
—
5
32
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
48
1.04
0.09
1.8
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
54
1.11
0.09
2.7
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
98
1.13
0.08
1.7
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
72
0.83
0.07
1.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
82
0.85
0.07
1.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
8
92
0.87
0.07
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
152
0.92
0.06
1.3
1.3
—
47.1
—
0
11
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
16
171
0.93
0.05
2.4
2.4
—
15.9
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
119
0.92
0.04
2.3
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
119
0.92
0.04
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
121
1.08
0.04
1.5
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
131
1.07
0.03
1.1
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
169
1702
0.98
0.03
4.1
3.6
pmol/l
14.9
14.8
0.18
156
1539
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
17
172
0.99
0.00
2.8
4.1
ng/l
93.3
77.4
0.65
17
150
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
42
418
1.01
0.00
2.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
592
1.00
0.00
2.8
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
36
359
1.00
0.00
1.2
1.3
u/ml
3.3
11.7
1.50
13
129
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
215
1.03
0.00
1.6
2.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
2.7
—
0
9
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
77
0.91
0.00
2.1
1.5
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
18.2
—
0
6
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
9.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
49
1.02
0.00
1.2
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
44.4
—
0
7
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
12.0
—
7.1
—
0
5
(4034850)
7
77
0.91
0.00
10.3
10.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
63.2
—
0
5
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
6
69
0.87
0.00
2.3
2.3
ug/min
66.0
82.1
—
6
41
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
166.8
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
7.5
—
0
7
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
85
0.94
0.00
1.0
1.4
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
7.9
—
0
9
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
70
1.00
0.00
1.4
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_LEUKAEMIA_NAS_EXALLC – Leukaemia of unspecified cell type
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).